week 9-12 Flashcards
The ‘Central Dogma of
Molecular Biology
describes the flow of genetic information in cells: DNA → RNA → Protein.
DNA stores genetic information.
Transcription: DNA is copied into mRNA.
Translation: mRNA is used to synthesize proteins at the ribosome.
This process is typically one-way, though exceptions like reverse transcription (in retroviruses) allow for some reversal of flow. The Central Dogma is essential for understanding how genetic information directs protein synthesis and cell function.
Proteomics
the study of the proteome, which consists of all the proteins expressed by a genome at any given time. Unlike the genome, which is stable, the proteome is dynamic and changes in response to environmental factors or cellular conditions. Proteins are responsible for various cellular functions and structural roles. Proteomics helps us understand how proteins contribute to traits (phenotype) and how their expression changes in response to different factors, at levels ranging from whole organisms to individual cells.
Proteome
The Proteome is the PROTEins expressed by a genOME at any one
time.
*The Proteome is constantly changing as cells respond to environmental
conditions
*It may be as complex as a whole organism, a tissue or a single cell type
Functional Diversity Resides in the
Proteome
PTMs
a single gene may give rise to more than one functional
protein due to the influence of chemical or physical
modifications to proteins
* PTMs are additions or subtractions to translated proteins
that can alter the chemical structure of a protein and
therefore modify its function
* PTMs can act as molecular ‘switches’ to turn on (or off)
enzyme activity
* By influencing structure, a PTM may influence how
proteins interact with other protein
Specific Example of PTM
Methylation – Methyl groups on several amino acids (Lys, Arg)
Post-translational modifications (PTMs) are classified into enzymatic and non-enzymatic types
Enzymatic PTMs involve specific enzymes adding or removing groups, such as:
Kinases (add phosphate) and phosphatases (remove phosphate).
Non-enzymatic PTMs occur without enzymes, including:
Oxidation (e.g., cysteine oxidation by reactive oxygen species).
These modifications regulate protein function and are important in cellular responses.
What are the functions of PTMs?
Alter protein structure/function relationship
› Influence protein-protein, protein-DNA, protein-ligand interactions
› Activate or repress activity (recycling)
› ‘Mark’ proteins for degradation/removal of a ‘signal’ peptide
Protein-Protein [ Protein-Biomolecule] Interactions
Proteins often interact with each other or other biomolecules (like DNA, RNA, or small molecules) to perform their functions. These interactions can result in the formation of protein complexes, where proteins may serve structural roles (e.g., support or transport) or enzymatic roles (e.g., catalysis). Protein complexes are temporary and enable various cellular processes.
protein tertiary structure and protein-protein interactions are largely determined by
hydrophobic interactions, charge-based interactions and hydrogen-bond
interactions, with other influences including disulfide bon
Examples of how PTMs can potentially alter
structure / function
A PTM alters charge-based interactions within protein
structure inhibiting the ability of an enzyme to bind it’s
substrate (or vice versa)
* A PTM alters hydrophobic interactions (e.g. by
increasing hydrophilicity) opening up a binding site for a
partner protein
* A PTM causes a protein to unfold and be targeted by
degradative processes
Reactive oxygen and reactive nitrogen species
(ROS/RNS) induce oxidative stress and PTM
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are free radicals that can cause oxidative stress by reacting with cellular components like proteins and DNA. They are produced continuously in biochemical processes and play roles in immune responses, such as macrophages using ROS to kill pathogens. However, excess ROS or compromised antioxidant defense systems can cause cellular damage. Defense proteins like superoxide dismutase (SOD), catalase, peroxiredoxins, and glutathione peroxidase help mitigate oxidative stress.
Antioxidants like Glutathione (GSH), Superoxide Dismutase (SOD), and Catalase (Kat) help remove reactive oxygen species (ROS) and protect cells from oxidative stress.
Glutathione (GSH): A tripeptide (glutamate-cysteine-glycine) that neutralizes free oxygen by oxidizing cysteine. A healthy cell maintains a GSH to GSSG (oxidized glutathione) ratio of 400:1.
the role of Cys redox PTMs
Redox signaling
* Protect against ‘over’ or irreversible oxidation
Cell signaling
biochemical mechanism through which cells sense environmental signals and initiate responses that involve the genome. The process involves the activation of membrane-bound or cytosolic receptors by extracellular stimuli. Key features of cell signaling include:
Receptors: Membrane receptors, like G-Protein Coupled Receptors (GPCRs) and Receptor Tyrosine Kinases (RTKs), detect external signals.
Transduction: Activated receptors can function as transcription factors or regulate downstream pathways through protein phosphorylation or second messengers.
Phosphorylation Cascade: Protein kinases add phosphate groups to proteins, activating or deactivating them, while phosphatases remove phosphate groups, regulating protein activity and amplifying the signal.
GPCR signaling involves:
Activation: External signals (e.g., epinephrine) bind to GPCRs, causing them to activate G-proteins.
G-Protein Activation: The G-protein exchanges GDP for GTP, becoming active.
Signal Transduction: Active G-protein regulates effector enzymes (e.g., adenylate cyclase), generating second messengers like cAMP.
Biological Effects: This signaling controls processes like glycogen breakdown, lipid hydrolysis, and heart rate increase in response to stress.
Termination: The signal ends when GTP is hydrolyzed to GDP, and second messenger levels are regulated.
Epinephrine-induced β-adrenergic signaling activates protein kinase A (PKA) through the production of cAMP. PKA then transmits the signal by phosphorylating target proteins. Key points:
Phosphorylation: A rapid, reversible, and coordinated process that amplifies the signal.
Signal Amplification: A single kinase activation can trigger the phosphorylation of many proteins.
PKA Activation: PKA phosphorylates key proteins, such as glycogen phosphorylase, which breaks down glycogen into glucose, enabling the body to respond to stress.
Protein kinases
Protein kinases add phosphate groups to specific sites on proteins, altering their function by introducing a negative charge. They can phosphorylate multiple sites and proteins, either specifically or broadly. Some kinases activate or deactivate other kinases, amplifying the signal and regulating cellular responses.
Signal amplification in GPCR
occurs when the activation of a GPCR by a substrate leads to the activation of multiple adenylyl cyclase enzymes. Each active adenylyl cyclase produces several cAMP molecules, which activate PKA. PKA, in turn, activates many targets, amplifying the signal and leading to the activation of thousands of glycogen-degrading enzymes in the liver. This amplification process magnifies the cellular response to the initial signal.
In GPCR signaling, PKA not only activates enzymes but also induces gene transcription. The process involves:
Activation of the GPCR.
Activation of adenyl cyclase by Gs and production of cAMP.
cAMP activates PKA, leading to the dissociation of PKA’s catalytic subunits, which then translocate to the nucleus.
PKA phosphorylates CREB (cAMP response element binding protein).
Phosphorylated CREB forms a complex with CBP/P300, enabling it to bind to CRE (cAMP response elements) in the promoters of cAMP-regulated genes, promoting their transcription.
This pathway allows for the long-term effects of signaling, including changes in gene expression.
Self-inactivation is crucial for terminating G-protein signaling, ensuring that signals like epinephrine, which are intended to be short-acting, don’t persist longer than needed.
Key steps in the termination of signaling include:
cAMP degradation: PKA activation is mediated by cAMP. To stop signaling, cAMP is degraded into AMP by cyclic nucleotide phosphodiesterase (cAMP phosphodiesterase).
G-protein inactivation: GTP bound to the Gs α-subunit is hydrolyzed to GDP upon signal withdrawal, leading to the inactivation of Gs.
Inhibitory G-protein (Gi): An increase in Gi, which inhibits adenyl cyclase, further reduces cAMP production.
These mechanisms ensure that the signaling pathway is shut down efficiently after its purpose is fulfilled.
Phosphoprotein phosphatases
remove phosphate groups from target proteins in response to cellular signals.
Oxytocin
(the ‘love hormone’) response is
via GPCR signaling
* Oxytocin is a neuropeptide hormone produced in the
hypothalamus and released by the pituitary gland
* Binds to a GPCR that activates G-protein ‘q’ (Gq)
activation by GTP and binding to membrane-associated
phospholipase C (PLC), initiating phosphatidylinositol
signaling
* PIP2 (phosphatidylinositol 4,5-bisphosphate) is cleaved
by PLC to diacylglycerol (DAG) and inositol 1,4,5-
trisphosphate; IP3)
* IP3 acts as the second messenger and initiates calcium
release from the ER, while DAG and Ca 2+ stimulate
protein kinase C (PKC
week 9 summary
- Signalling involves the binding of a signal molecule (e.g. hormone) to a
specific receptor (GPCRs and others) - Activated receptor results in disassociation of an enzyme activating protein (A
G-protein) which in turn activates a membrane-localized enzyme (adenyl
cyclase) - A second messenger (cAMP) activates protein kinases (PKA) that amplify the
signal without altering protein expression - Activated kinases phosphorylate multiple target proteins at consensus motifs
to alter their structure / function - Activated kinase signal transduction ultimately leads to a change in gene
transcription - Feedback mechanisms exist to dampen and ultimately stop the response
upon reduction or removal of the stimulus
What is the primary function of Gq in oxytocin signaling?
a) To activate protein kinase A (PKA)
b) To activate phospholipase C (PLC)
c) To release calcium from the endoplasmic reticulum (ER)
d) To bind to diacylglycerol (DAG)
to activate phospholipase C (PLC)
Which of the following molecules is generated when phospholipase C cleaves PIP2?
a) cAMP and calcium
b) DAG and IP3
c) cAMP and PKA
d) ATP and IP3
DAG and IP3
What is the role of IP3 in oxytocin signaling?
a) It activates protein kinase C (PKC)
b) It promotes the synthesis of oxytocin
c) It triggers calcium release from the endoplasmic reticulum (ER)
d) It binds to G-protein Gq
It triggers calcium release from the endoplasmic reticulum (ER)
Receptor Tyrosine Kinases (RTKs):
RTKs are a family of ~60 membrane receptors that mediate extracellular signal transduction via autophosphorylation.
RTK structure:
Extracellular ligand-binding domain.
Single transmembrane domain.
Intracellular tyrosine kinase domain.
They are activated by ligand binding (e.g., epidermal growth factor (EGF) or insulin).
Ligand binding induces receptor dimerization, activating the tyrosine kinase domain, which autophosphorylates tyrosine residues and provides docking sites for downstream signaling proteins.
Insulin Signaling via RTKs:
Insulin is produced by pancreatic β-cells and binds to the insulin receptor (INSR) on target cells (liver, muscle, fat).
The insulin receptor is a dimer consisting of two α-chains and two β-chains. Binding activates the intracellular kinase domain, leading to phosphorylation of tyrosine residues.
Insulin receptor substrate-1 (IRS-1) is phosphorylated, triggering downstream signaling pathways, including:
MAPK signaling (Ras/Raf): Activation of Ras leads to Raf, then to ERK, which stimulates gene expression.
PI3K/Akt signaling: Activation of PI3K produces PIP3, which activates Akt, leading to effects such as glucose uptake and gene expression.
Insulin Signaling Pathways
MAPK signaling: ERK enters the nucleus, phosphorylates transcription factors (e.g., Elk1), and stimulates gene expression like glucose transporters.
PI3K/Akt signaling: Akt phosphorylates various targets, such as FOXO transcription factors, to regulate gene expression and glucose metabolism.
GLUT4 translocation: Akt phosphorylates TBC1D4, enabling GLUT4 vesicles to move to the cell surface for glucose uptake.
Termination of Insulin Signaling
Phosphatases (e.g., PTEN) deactivate signaling by removing phosphates from proteins.
Endocytosis of the insulin receptor complex leads to receptor degradation, reducing sensitivity to insulin.
Ser/Thr phosphatases (e.g., PP2A, PHLPP) also inhibit Akt signaling.
Ubiquitination and degradation of IRS proteins can also downregulate insulin signaling.
Research Insights
Phosphoproteomics provides insights into the temporal dynamics of insulin signaling.
Ongoing research reveals new signaling pathways and mechanisms involved in insulin action and metabolic regulation.
week 10 summary
RTKs, like the insulin receptor, mediate complex signaling pathways that lead to diverse physiological effects.
Cross-talk between pathways can modulate insulin signaling outcomes.
New insights into insulin signaling mechanisms are continuously being discovered.